(Q47817766)

5 February 2018

title

Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice. (English)

1 reference

5 February 2018

author name string

Junseo Oh

1

1 reference

5 February 2018

Rei Takahashi

2

1 reference

5 February 2018

Eijiro Adachi

3

1 reference

5 February 2018

Shunya Kondo

4

1 reference

5 February 2018

Shinobu Kuratomi

5

1 reference

5 February 2018

Akinori Noma

6

1 reference

5 February 2018

David B Alexander

7

1 reference

5 February 2018

Hirotoshi Motoda

8

1 reference

5 February 2018

Akiko Okada

9

1 reference

5 February 2018

Motoharu Seiki

10

1 reference

5 February 2018

Takeshi Itoh

11

1 reference

5 February 2018

Shigeyoshi Itohara

12

1 reference

5 February 2018

Chiaki Takahashi

13

1 reference

5 February 2018

Makoto Noda

14

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 June 2004

1 reference

5 February 2018

published in

Oncogene

1 reference

5 February 2018

volume

23

1 reference

5 February 2018

page(s)

5041-5048

1 reference

5 February 2018

issue

29

1 reference

5 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207688

exact match

0 references

cites work

Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

Dystroglycan in development and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

Myogenesis in the mouse embryo: differential onset of expression of myogenic proteins and the involvement of titin in myofibril assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

Dose-dependent limitation of arterial enlargement by the matrix metalloproteinase inhibitor RS-113,456.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

Unusual laminin alpha2 processing in myoblasts from a patient with a novel variant of congenital muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

Matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

Arterial enlargement in response to high flow requires early expression of matrix metalloproteinases to degrade extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

Congenital myopathies and congenital muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

Expression of cytoskeleton proteins in central core disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

Rat myoblast fusion requires metalloendoprotease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

7 January 2021

Furin and membrane type-1 metalloproteinase mRNA levels and activation of metalloproteinase-2 are associated with arterial remodeling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

7 January 2021

In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

7 January 2021

Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

7 January 2021

MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

7 January 2021

Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

7 January 2021

Efficient selection for high-expression transfectants with a novel eukaryotic vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

7 January 2021

The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

7 January 2021

Fibronectin delays the fusion of L6 myoblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

7 January 2021

Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

7 January 2021

A matrix metalloproteinase expressed on the surface of invasive tumour cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

7 January 2021

Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

7 January 2021

Role of Matrix Metalloproteinases in Blood Flow–Induced Arterial Enlargement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

7 January 2021

Immunophenotyping of congenital myopathies: disorganization of sarcomeric, cytoskeletal and extracellular matrix proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

7 January 2021

MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

7 January 2021

Matrix metalloproteinases: effectors of development and normal physiology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

7 January 2021

ECM and cell surface proteolysis: regulating cellular ecology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207688

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207688

1 reference

5 February 2018

PubMed ID

15064723

1 reference

5 February 2018